Table 4.
Median survivals | 1-year survival | 3-year survival | 5-year survival | Log-rank test (P) | |
---|---|---|---|---|---|
months | (%) | (%) | (%) | X2 | |
Colorectal cancer | |||||
CC-0,-1 (N = 62) | 38.4 | 93 | 51 | 28 | P = 0.003 |
CC-2,-3 (N = 19) | 19.2 | 33 | 16 | 0 | X2 = 8.53 |
PCI ≤ 10 (N = 45) | NR | 95 | 59 | 59 | P < 0.001 |
PCI ≥ 11(N = 36) | 18.2 | 83 | 37 | 0 | X2 = 12.90 |
Appendiceal neoplasm | |||||
CC-0,-1 (N = 228) | NR | 99 | 93 | 84 | P < 0.001 |
CC-2,-3 (N = 192) | NR | 91 | 69 | 50 | X2 = 41.48 |
PCI ≤ 28 (N = 257) | NR | 99 | 89 | 76 | P < 0.001 |
PCI ≥ 29 (N = 163) | 49.2 | 87 | 63 | 55 | X2 = 38.81 |
Gastric cancer | |||||
CC-0,-1 (N = 101) | 21.5 | 70 | 26 | 17 | P < 0.001 |
CC-2,-3 (N = 65) | 13.6 | 59 | 8 | 2 | X2 = 14.90 |
PCI ≤ 6 (N = 111) | 21.5 | 76 | 23 | 14 | P < 0.001 |
PCI ≥ 7 (N = 55) | 13.6 | 57 | 21 | 3 | X2 = 10.48 |